| For Apheresis Professionals |
ASFA 2010 Webinar Schedule
|
2010 Webinar Descriptions
Apheresis Support of Stem Cell Transplant
January 20,2010 (12pm – 1pm ET)
Presenter: Micheal Linenberger, MD - Seattle Cancer Care Alliance, WA
Learning Objectives:
- Highlight the advances and challenges in the collection and infusion of blood hematopoietic progenitors (HPCs) for hematopoietic stem cell transplantation (HCT)
- Discuss the roles of apheresis for preparing patients and marrow HPC products for HCT
- Review indications for therapeutic apheresis procedures for posttransplant complications and patient responses
Automated Collections FDA Guidance Documents
February 24, 2010 (12pm – 1pm ET)
Presenter: Sheryl Kempin, RN, BSHA - Blood Systems Inc., AZ
- Review the impact of implementation of 2007 Collection of Platelets by Automated Methods and the 2001 Recommendation for Collecting Red Blood Cells by Automated Methods
- Provide examples form industry for meeting the monthly QC criteria for both documents
- Provide examples of the operational impact of the validation process on collections
Click
Here to Purchase a CD
^top
Management of Poor Stem Cell Mobilization, Updates on New Stem Mobilization Agents
^top
Management of Poor Stem Cell Mobilization, Updates on New Stem Mobilization Agents
March 10, 2010 (12pm – 1pm ET)
Presenter: YanYun Wu, MD - Yale University School of Medicine, CT
Learning Objectives:
- Review the mechanism of stem cell mobilization
- Review conventional approach of managing poor mobilization
- Review new Stem Mobilization Agents
Click
Here to Purchase a CD
^top
An Overview of Coagulation and Anticoagulants in 2010: The clot thickens....
April 21, 2010 (12pm - 1pm ET)
Presenter: Sergio Torloni, MD - Mayo Clinic, AZ
Learning Objectives:
The Use of CD34+ Stem Cells in Patients with Refractory Angina
May 12, 2010 (12pm - 1pm ET)
Presenter: Jay Traverse, MD - Minneapolis Heart Institute at Abbott Northwestern Hospital, MN
Learning Objectives:
^top
Leukapheresis in Acute Leukemia
June 16, 2010 (12pm – 1pm ET)
Presenters: Jan Hofmann, MD - Apheresis Care Group California, CA
Regina Rohe, RN, BS, HP(ASCP) - Fresenius Medical Care, NA, CA
Jan Hofmann is the Associate Medical Director at Apheresis Care Group California, Pacific Medical Center, San Francisco. He has 16 years of clinical experience in therapeutic apheresis and has supervised over 400 leukocytapheresis treatments during the past 5 years.
Regina Rohe, RN, BS, HP (ASCP) is Regional Vice President of Inpatient Services for Fresenius Medical Care North America.Ms. Rohe is an accomplished senior healthcare executive with over 25 years of clinical and administrative experience in therapeutic apheresis in the United States.She has numerous publications and is a frequently invited speaker at both national and international apheresis conferences.
Click Here to Purchase a CD
^top
Highlights of the ASFA 2010 Annual Meeting
June 30, 2010 (12pm – 1pm ET)
Presenters: Salil Joshi, MD - St. Jude's Children's Hospital, TN
Zbigniew “Ziggy” M. Szczepiorkowski, MD, PhD, FCAP for ASFA Categories Subcommittee, Dartmouth-Hitchcock Medical Center, NH
Highlights of the ASFA 2010 Annual Meeting Topics and Learning Objectives:
Zbigniew (Ziggy) M. Szczepiorkowski, MD, PhD graduated from the Medical University of Warsaw, Poland. He was an intern in Mokotowski Hospital, Warsaw, Poland followed by a postdoctoral fellowship at Massachusetts General Hospital/Harvard Medical School. He obtained his PhD in Medicine at the Medical Center for Postgraduate Education in Warsaw, Poland. He was a resident and the chief resident in Clinical Pathology at Massachusetts General Hospital in Boston, Massachusetts.
Dr. Szczepiorkowski is currently an Associate Professor of Pathology and of Medicine at Dartmouth Medical School.He is Medical Director of the Transfusion Medicine Service and Center for Transfusion Medicine Research; and Director of the Cellular Therapy Center at Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire. He is also an Investigator at Norris Cotton Cancer Center, (NCI Comprehensive Cancer Center at Dartmouth), and a Consultant in Pathology Services at the Massachusetts General Hospital.
Dr. Szczepiorkowski is Immediate Past President of the American Society for Apheresis. He is also a member of the Board of Directors of AABB and National Marrow Donor Program. Dr. Szczepiorkowski is a co-leader of Cellular Therapy Team of the BEST Collaborative.Dr. Szczepiorkowski chairs committees of ASFA and of the NMDP. He served as a member of executive and advisory committee of the Center for International Blood and Marrow Transplantation Research (CIBMTR). Dr. Szczepiorkowski has also served on NHLBI SBIR, NIH ad hoc panels, various committees of AABB, ASFA, College of American Pathologist (CAP), Foundation for the Accreditation of Cellular Therapy (FACT), and the National Marrow Donor Program (NMDP). He has over 60 publications in the field of laboratory medicine, cellular therapy, apheresis, and transfusion medicine.His current research includes studies of adaptive immunotherapy in cancer, the clinical use of apheresis, and analysis of cellular therapy products.
^top
Physician Billing for Therapeutic Apheresis Services
July 21, 2010 (12pm – 1pm ET)
Presenter: Keith Berman, MPH, MBA - Health Research Associates, Pasadena, CA
Learning Objectives:
Pediatric Apheresis: Red Cell Exchange for Sickle Cell Disease
September 15, 2010 (12pm – 1pm ET)
Dr. Joseph Schwartz and Dr. Anand Padmanabhan
Presenters: Joseph Schwartz, MD - Columbia University Medical Center, NY
Anand Padmanabhan, MD - BloodCenter of Wisconsin, WI
Learning Objectives:
Anand Padmanabhan MD, PhD has been involved in the care of numerous pediatric sickle cell patients at the Children's hospital of New York, Pittsburgh and currently oversees procedures at the Children's Hospital of Wisconsin.
Click Here to Register Now
^top
Review of Apheresis Machines and Basic Operations Principle
October 20, 2010 (12pm – 1pm ET)
Presenter: Edwin A. Burgstaler, MT, HP(ASCP) - Mayo Clinic, MN
Click Here to Register Now
^top
Granulocyte Transfusion
November 17, 2010 (12pm - 1pm ET)
Presenter: Thomas Price, MD - Puget Sound Blood Center, WA
Click Here to Register Now
^top
Apheresis Support for ABO Incompatible Renal Transplants
December 8, 2010 (12pm - 1pm ET)
Presenter: Karen King, MD, John Hopkins Hospital, Baltimore, MD
Click Here to Register Now
^top
^top
An Overview of Coagulation and Anticoagulants in 2010: The clot thickens....
April 21, 2010 (12pm - 1pm ET)
Presenter: Sergio Torloni, MD - Mayo Clinic, AZ
Learning Objectives:
- Understand basic mechanisms of coagulation
- Be aware of different tests available to evaluate the coagulation cascade and how to use them
- Understand the mechanism of action of most common anticoagulants and anti-platelet drugs
Click
Here to Purchase a CD
^top
The Use of CD34+ Stem Cells in Patients with Refractory Angina
May 12, 2010 (12pm - 1pm ET)
Presenter: Jay Traverse, MD - Minneapolis Heart Institute at Abbott Northwestern Hospital, MN
Learning Objectives:
- Describe the extent and natural history of patients with refractory angina (chest pain)
- Describe the pre-clinical studies demonstrating the actions of CD34+ cells in promoting neovascularization
- Describe the results of a recent Phase II clinical trial demonstrating the benefits of CD34+ stem cell administration in patients with refractory angin
Dr. Traverse is a senior consulting cardiologist at the Minneapolis Heart Institute and an Associate Professor of Medicine in the Cardiovascular Division at the University of Minnesota.
^top
Leukapheresis in Acute Leukemia
June 16, 2010 (12pm – 1pm ET)
Presenters: Jan Hofmann, MD - Apheresis Care Group California, CA
Regina Rohe, RN, BS, HP(ASCP) - Fresenius Medical Care, NA, CA
Learning Objectives:
- Understand the clinical presentation of hyperleukocytosis and acute leukemia, and recognize when leukocytapheresis (leukodepletion) is an appropriate therapy
- Become
familiar
with the medical literature
on the use of
leukocytapheresis in the treatment of acute leukemia
- Recognize the specific issues pertinent to performing leukocytapheresis safely and effectively
Jan Hofmann is the Associate Medical Director at Apheresis Care Group California, Pacific Medical Center, San Francisco. He has 16 years of clinical experience in therapeutic apheresis and has supervised over 400 leukocytapheresis treatments during the past 5 years.
Regina Rohe, RN, BS, HP (ASCP) is Regional Vice President of Inpatient Services for Fresenius Medical Care North America.Ms. Rohe is an accomplished senior healthcare executive with over 25 years of clinical and administrative experience in therapeutic apheresis in the United States.She has numerous publications and is a frequently invited speaker at both national and international apheresis conferences.
Click Here to Purchase a CD
^top
Highlights of the ASFA 2010 Annual Meeting
June 30, 2010 (12pm – 1pm ET)
Presenters: Salil Joshi, MD - St. Jude's Children's Hospital, TN
Zbigniew “Ziggy” M. Szczepiorkowski, MD, PhD, FCAP for ASFA Categories Subcommittee, Dartmouth-Hitchcock Medical Center, NH
Highlights of the ASFA 2010 Annual Meeting Topics and Learning Objectives:
- Access Issues by Dr. Salil Joshi
- Choices for central venous catheters
- Key issues during placement of central catheters
- Complications and trouble shooting of non functioning central catheters
- Update on JCA New Special Edition by Dr. Zbigniew Szczepiorkowski
- Describe the process used by ASFA to evaluate the evidentiary basis for apheresis therapy of clinical disorders.
- Describe the main changes between the JCA Special Issue 2007 and 2010
- Discuss the impact of recommendation grades on clinical decision
Zbigniew (Ziggy) M. Szczepiorkowski, MD, PhD graduated from the Medical University of Warsaw, Poland. He was an intern in Mokotowski Hospital, Warsaw, Poland followed by a postdoctoral fellowship at Massachusetts General Hospital/Harvard Medical School. He obtained his PhD in Medicine at the Medical Center for Postgraduate Education in Warsaw, Poland. He was a resident and the chief resident in Clinical Pathology at Massachusetts General Hospital in Boston, Massachusetts.
Dr. Szczepiorkowski is currently an Associate Professor of Pathology and of Medicine at Dartmouth Medical School.He is Medical Director of the Transfusion Medicine Service and Center for Transfusion Medicine Research; and Director of the Cellular Therapy Center at Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire. He is also an Investigator at Norris Cotton Cancer Center, (NCI Comprehensive Cancer Center at Dartmouth), and a Consultant in Pathology Services at the Massachusetts General Hospital.
Dr. Szczepiorkowski is Immediate Past President of the American Society for Apheresis. He is also a member of the Board of Directors of AABB and National Marrow Donor Program. Dr. Szczepiorkowski is a co-leader of Cellular Therapy Team of the BEST Collaborative.Dr. Szczepiorkowski chairs committees of ASFA and of the NMDP. He served as a member of executive and advisory committee of the Center for International Blood and Marrow Transplantation Research (CIBMTR). Dr. Szczepiorkowski has also served on NHLBI SBIR, NIH ad hoc panels, various committees of AABB, ASFA, College of American Pathologist (CAP), Foundation for the Accreditation of Cellular Therapy (FACT), and the National Marrow Donor Program (NMDP). He has over 60 publications in the field of laboratory medicine, cellular therapy, apheresis, and transfusion medicine.His current research includes studies of adaptive immunotherapy in cancer, the clinical use of apheresis, and analysis of cellular therapy products.
^top
Physician Billing for Therapeutic Apheresis Services
July 21, 2010 (12pm – 1pm ET)
Presenter: Keith Berman, MPH, MBA - Health Research Associates, Pasadena, CA
Learning Objectives:
- Review coding and billing basics
- Documenting the physician's apheresis supervision
- When to bill apheresis and evaluation and management (E/M) services
Mr. Berman is a business development and reimbursement consultant for the blood products and apheresis services industry. On behalf of professional societies and industry clients, he advocates for appropriate insurance billing and payment policies to assure continuing patient access to therapeutic apheresis and other life-critical therapies.
Click Here to Purchase a CD
^top
Pediatric Apheresis: Red Cell Exchange for Sickle Cell Disease
September 15, 2010 (12pm – 1pm ET)
Dr. Joseph Schwartz and Dr. Anand Padmanabhan
Presenters: Joseph Schwartz, MD - Columbia University Medical Center, NY
Anand Padmanabhan, MD - BloodCenter of Wisconsin, WI
Learning Objectives:
- Understand the pathophysiology of and the morbidity/mortality associated with sickle cell disease
- Discuss treatment options for sickle cell disease patients, with a focus on apheresis treatments
- Appreciate the challenges and opportunities in instituting apheresis treatment in pediatric patients
Anand Padmanabhan MD, PhD has been involved in the care of numerous pediatric sickle cell patients at the Children's hospital of New York, Pittsburgh and currently oversees procedures at the Children's Hospital of Wisconsin.
Click Here to Register Now
^top
Review of Apheresis Machines and Basic Operations Principle
October 20, 2010 (12pm – 1pm ET)
Presenter: Edwin A. Burgstaler, MT, HP(ASCP) - Mayo Clinic, MN
Click Here to Register Now
^top
Granulocyte Transfusion
November 17, 2010 (12pm - 1pm ET)
Presenter: Thomas Price, MD - Puget Sound Blood Center, WA
Click Here to Register Now
^top
Apheresis Support for ABO Incompatible Renal Transplants
December 8, 2010 (12pm - 1pm ET)
Presenter: Karen King, MD, John Hopkins Hospital, Baltimore, MD
Click Here to Register Now
^top